Form D · Pharmaceuticals
M2G Med-Management LLC
Nashville, TN · CIK 0001511791
Offering snapshot reported Feb 18, 2011 · SEC filing
- Reported sold
- $1.33M Offering amount: $1.5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $30.1K Reported outside-investor minimum
- First sale
- Feb 9, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 18, 2011 | Initial | $1,331,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-155634
Source: Form D, filed Feb 18, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Clements | Director, Executive |
| Austin Davis | Executive |
| Robert H. Edwards, Jr. | Director |
| Norman J. Noffsinger, D.Ph. | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1838 Elm Hill Pike, Suite 125
Nashville, TN, 37210
Nashville, TN, 37210